Skip to search formSkip to main contentSkip to account menu

somatostatin receptor 4

Known as: sst4 receptor, SSTR4 protein, sst(4) receptor 
National Institutes of Health

Related topics

Related topics

3 relations
SSTR4 gene

Narrower (1)

SSTR4 protein, human

Broader (1)

Somatostatin Receptor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Somatostatin Receptor Subtype-4 Regulates mRNA Expression of Amyloid-Beta Degrading Enzymes and Microglia Mediators of Phagocytosis in Brains of 3xTg-AD Mice
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder resulting in memory and cognitive impairment. The use of… 
2019
2019
Novel Somatostatin Receptor Subtype‐4 Agonist Mitigates Microglia Inflammatory Activation
This research evaluated the impact of novel somatostatin receptor subtype‐4 (SSTR4) agonist SM‐I‐26 on microglia inflammatory… 
2018
2018
Discovery of a 3,4,5-trisubstituted-1,2,4-triazole agonist with high affinity and selectivity at the somatostatin subtype-4 (sst4) receptor.
A series of compounds containing a 1,2,4-triazole moiety were synthesized, targeting the somatostatin receptor subtype-4 (sst4… 
2017
2017
The protective effects of magnolol on acute trinitrobenzene sulfonic acid-induced colitis in rats
The present study aimed to investigate the protective effects of magnolol on acute 2,4,6-trinitrobenzene sulfonic acid (TNBS… 
2017
2017
Childhood Adversities are not a Predictors of SSTR4met in Alcoholics
Abstract Background Genome methylation may modulate synaptic plasticity, being a potential background for mental disorder… 
2016
2016
Electroacupuncture pretreatment with different waveforms prevents brain injury in rats subjected to cecal ligation and puncture via inhibiting microglial activation, and attenuating inflammation…
2014
2014
Somatostatin 4 receptor activation modulates G-protein coupled inward rectifying potassium channels and voltage stimulated calcium signals in dorsal root ganglion neurons.
2013
2013
Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ42 oligomers via a metalloproteinase-dependent mechanism
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)